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Borna disease virus (BDV) causes a central nervous system disease in several vertebrate species which is characterized
by behavioral disturbances. Seroepidemiological data indicate an association of BDV infection with certain human mental
disorders. Sclerosis of the hippocampus and astrocytosis constitute histopathological hallmarks of BDV infection in animals.
Therefore, we searched for human brain autopsy cases with such histopathological features. Five of 600 cases examined
were identified as having hippocampus sclerosis and astrocytosis. Using immunocytochemistry, RT-PCR, and in situ hybridiza-
tion, we detected both BDV antigen and RNA in autopsy brain samples from 4 of these 5 patients, who presented with a
clinical history of mental disorders involving memory loss and depression. This is the first demonstration that BDV can
infect human brain tissue, possibly contributing to the pathophysiology of specific human neuropsychiatric disorders.
q 1996 Academic Press, Inc.
INTRODUCTION brate species which is manifested by behavioral abnor-
malities and diverse pathological manifestations de-
Evidence indicates that both genetic and environmen- pending on the species, age, and immune status of the
tal determinants play a role in the etiology of psychiatric host, as well as the route of infection and virus strain
disorders (Morozov, 1983; Yolken and Torrey, 1995). Epi- (Rott and Becht, 1995). Heightened viral expression in
demiological and clinical findings, together with the ob- limbic system structures, as well as astrocytosis and
servation that viruses can persist in the central nervous neuronal degeneration within the hippocampal forma-
system (CNS) (Kristensson and Norrby, 1986; ter Meulen, tion, constitute the main histopathological hallmarks of
1991) and cause behavioral disturbances as the main BDV infection in different animal species (Carbone et al.,
manifestation of infection (Kristensson and Norrby, 1986; 1991; Gosztonji and Ludwig, 1995). Inflammatory infil-
Mohammed et al., 1993; ter Meulen, 1991), have led to trates are often, but not always, observed in the brain of
the hypothesis that viruses may contribute to neuropsy- infected animals (Carbone et al., 1991; Rott and Becht,
chiatric disorders of unknown etiology (Morozov, 1983; 1995).
ter Meulen, 1991). Seroepidemiological studies indicate a significantly
Borna disease virus (BDV) is a nonsegmented, nega- higher seroprevalence of BDV in patients with neuropsy-
tive-stranded (NNS) RNA virus (Briese et al., 1994; Cubitt chiatric disorders than in healthy controls (Bode, 1995).
et al., 1994a; de la Torre, 1994; Schneemann et al., 1995) With the hypothesis that BDV is involved in such mental
with a nuclear site for the replication and transcription disorders, it would be reasonable to predict the presence
of its genome (Cubitt and de la Torre, 1994; de la Torre, of markers of BDV in the CNS of such patients. To test
1994; Schneemann et al., 1995), and the use of RNA this hypothesis, we analyzed autopsy brain material from
splicing for its gene expression regulation (Cubitt et al., patients with well-documented clinical and histopatho-
1994b; Schneider et al., 1994). These features signal BDV logical records for the expression of BDV markers. Here,
as the prototype of a new group of animal viruses (de we report for the first time the detection of BDV-specific
la Torre, 1994; Schneemann et al., 1995). BDV is also antigen and RNA in the CNS of patients who presented
characterized by being noncytolytic and highly neuro- with a history of mental disorders.
tropic.
MATERIALS AND METHODSBDV causes CNS disease in several nonhuman verte-
Samples
Degeneration of neurons within the hippocampal for-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (619) 554 9981; E-mail: juanct@riscsm.scripps.edu. mation and intense astrocytosis have been documented
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as the main histopathological findings in BDV-infected with clarified lysates from Sf9 cells (107 cells) infected
with either a wild-type baculovirus or a recombinantanimals (Carbone et al., 1991; Rott and Becht, 1995).
Therefore we conducted a survey of a total of 600 autopsy baculovirus expressing the BDV p40 antigen. Details
describing the construction of this baculovirus recom-cases that are part of the Alzheimer Disease Research
Center (ADRC) neuropathology database at the Univer- binant and preparation of cell extracts for blocking ex-
periments are described elsewhere (Sauder et al.,sity of California, San Diego, to identify cases with similar
histopathological characteristics. Five cases were found manuscript submitted).
which displayed significant hippocampal sclerosis (HS),
DNA transfection, immunofluorescence, Western blot,defined as significant atrophy of the hippocampus as a
and immunoprecipitationresult of marked degeneration of neuronal populations
accompanied by widespread gliosis. Cases in the ADRC
Cells were transfected with a plasmid DNA (CMV-
corresponding to patients with prolonged premortem de-
BDVp40) expressing the BDV p40 gene product under
lay, which caused severe hypoxia due to lung damage,
control of a cytomegalovirus immediate-early promoter
and who at autopsy showed marked neuronal loss in the
using lipofectamine according to the manufacturer’s
CA1 region were excluded from our studies.
(GIBCO BRL) instructions. For immunofluorescence stud-
A total of 36 cases was selected for this study. These
ies, cells were grown on 12-mm circle coverslips, cul-
included the 5 HS cases; 26 randomly chosen cases had
tured overnight, and transfected as described above.
clinical histories of Alzheimer Disease (AD), confirmed
Twenty-four hours after transfection, cells were analyzed
at autopsy; 3 cases had a clinical history of dementia
by indirect immunofluorescence as described (Cubitt and
and mild parkinsonism and were diagnosed as having
de la Torre, 1994).
the Lewy body variant (LBV) of AD at autopsy; 2 cases
Whole-cell extracts from uninfected and BDV persis-
were clinically and histopathologically free of neurologi-
tently infected C6 cells (Cubitt and de la Torre, 1994), as
cal disease. Prior to death, all these cases were neuro-
well as from C6 cells transfected with the CMV-BDVp40
logically and neuropsychologically evaluated as de-
plasmid DNA, were prepared and analyzed by Western
scribed (Terry et al., 1991). For all these cases 10% para-
blot as described (Sambrook et al., 1989). For immuno-
formaldehyde-fixed as well as unfixed frozen tissue was
precipitation assays, cell monolayers were incubated in
available. Autopsies were performed within 8 hr postmor-
methionine-free medium for 1 hr prior to radiolabeling
tem. Paraffin-embedded sections from cortical and sub-
for 4 hr in methionine-free medium containing 20 mCi/ml
cortical regions were sectioned at 7 mm and stained with
[35S]methionine. Whole-cell extracts were prepared and
hematoxylin/eosin (H/E), thioflavine-S, and cresyl violet
immunoprecipitated using the rabbit anti-BDVp40 serum
for routine histopathological examination and morpho-
and Pansorbin cells (Calbiochem) as described (Sam-
metric analysis as described (Terry et al., 1981). Unfixed
brook et al., 1989). Proteins were analyzed by electropho-
tissue samples collected from the same areas were
resis in 10% polyacrylamide gels by using the buffer sys-
stored frozen at 0707.
tem of Laemmli (Sambrook et al., 1989).
Immunocytochemical analysis Detection of BDV RNA by RT-PCR
RNA was extracted from frozen brain tissue samplesHippocampal sections from all 36 cases were immu-
nolabeled as described (Masliah et al., 1991) with a using the guanidium isothiocyanate/acid phenol method
(Chomczynski and Sacchi, 1987). Total RNA (5 mg) wasrabbit polyclonal antibody that specifically recognizes
the BDV p40 antigen, as well as with a polyclonal anti- reverse-transcribed using 200 units of SuperScript II
RNase H0 reverse transcriptase (RT) (GIBCO BRL) andbody (BioGenix, Inc.) against the glial fibrillary acidic
protein (GFAP) to evaluate the characteristics of the random hexamers (14 pmol/ml) as described (de la Torre
et al., 1996). cDNAs were treated with RNase H (2 units)astroglial response. Binding of the first antibody was
detected with a biotinylated goat anti-rabbit IgG serum, for 10 min at 377 prior to PCR amplification. BDV-specific
RNA corresponding to BDV p40 was detected by nestedfollowed by incubation with Avidin D-HRP (ABC ELITE;
Vector Laboratories, Burlingame, CA) using diamino- PCR. The first PCR was done using 1/10 of the cDNA
product and BDV primers BV259F (antigenomic polarity)benzidine as a substrate (Masliah et al., 1991). Unin-
fected and BDV persistently infected cultured cells and BV829R (genomic polarity), corresponding to nucleo-
tide (nt) positions 259 to 278 and 808 to 829, respectively,were used as negative and positive controls, respec-
tively. In addition, uninfected and BDV-infected cells, in the BDV genome (Cubitt et al., 1994a; de la Torre,
1994). Samples were amplified for 40 cycles (947/577/727,as well as brain sections, were stained with the preim-
mune rabbit serum. 1 min each) followed by a final polymerization extension
step for 10 min at 727. The second PCR was done usingTo verify the specificity of the staining for BDV p40
antigen, hippocampal sections were stained with the 1/25 of the RT-PCR product and the nested set of BDV
primers: BV277F (antigenomic polarity) and BV805R (ge-antibody that had been preadsorbed at 47 for 12 hr
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FIG. 1. Histopathology of representative AD and HS cases. Macroscopic examination of brain sections from (A) one AD and (B) one HS case.
Comparison of dentate gyrus (DG) and pyramidal layer (PL) between (C) AD and (D) HS cases showing a decreased number of cells within the PL
in the HS case. Detail of the histopathological findings within the PL of (E) AD and (F) HS cases showing the loss of neurons in the HS case.
nomic polarity), corresponding to nt positions 277 to 297 with specific primers to generate a 192-bp GAPDH frag-
ment as described (de la Torre et al., 1996). Each RT-and 786 to 805, respectively, in the BDV genome (Cubitt
et al., 1994a; de la Torre, 1994). Amplification was done PCR assay also included two water samples as negative
controls of environmental contamination and a BDV-neg-using the same cycle conditions as in the first PCR. Con-
ditions for PCR reactions were as described (de la Torre ative C6 RNA sample.
et al., 1996). The set of nested primers used amplifies a
528-bp segment of BDV p40. The BDV specificity of the In situ hybridization of brain sections
RT-PCR products was determined by Southern blot hy-
bridization using a 32P-labeled probe corresponding to Seven-micrometer-thick paraffin brain sections were
cut on a rotary microtome, deparaffinized, and processedinternal sequences of the BDV p40 528-bp segment. As
a control for RNA quality, cDNAs were also amplified for in situ hybridization (ISH) as described (Brahic and
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TABLE 1
Summary of Clinicopathological Characterisitics
Disease Brain Frontal Frontal
duration Blessed Age weight tangles plaques
Diagnosisa N (years) scoreb (years) (grams) (0.1 sq mm) (1.6 sq mm)
Control 2 0 0 80 { 8.5 1206 { 6 0 0
Alzheimer’s disease 26 7.7 { 0.5 23 { 2 77 { 1.5 1067 { 29 3 { 0.5 44 { 2
Hippocampus sclerosis 5 5.5 { 1.1 15 { 4 84 { 5 1121 { 34.5 0 49 { 11
Lewy body variant 3 9.3 { 1.8 26 { 2 74 { 5 909 { 23 0.6 { 0.3 39 { 5
a Neuropsychological and neurological evaluation of patients was conducted as described (Terry et al., 1991). Assessment of neuropathology at
autopsy was done as described (Masliah et al., 1991).
b Blessed score reflects global cognitive performance. The scale is from 0 to 33, 0 being normal and 33 representing the most severe cognitive
impairment (Terry et al., 1991).
Ozden, 1992). An antisense riboprobe corresponding to hybridization for 16 hr at 507, the sections were washed
in 51 SSC, 10 mM DTT for 30 min at 427, then in 21full-length BDV p40 (1113 nt) was generated by in vitro
transcription in the presence of [35S]UTP (final concentra- SSC, 50% formamide, 10 mM DTT for 20 min at 607. This
was followed by two 10-min washes in washing solutiontion 2.5 mM) using the T7 RNA polymerase. The RNA
probe was partially hydrolyzed in 40 mM NaHCO3 , 60 (0.1 M Tris–HCl, pH 7.5, 0.4 M NaCl, 0.05 M EDTA) at
377. The slides were then treated with RNase A (1 mg/mM Na2CO3 , pH 10.2, for 1 hr at 607 and purified by
chromatography on a Sephadex G50 column. Riboprobes ml in washing solution) for 30 min at 377, rinsed for 15
min at 377 in washing solution, then washed once in 21used had a specific activity of 2.2 1 109 dpm/mg. The
hybridization mixture contained 50% formamide, 0.3 M SSC and once in 0.11 SSC (15 min at 377 each time)
before dehydration in ethanol. The slides were dippedNaCl, 20 mM Tris–HCl (pH 7.4), 5 mM EDTA, 10 mM
NaH2PO4 (pH 8), 10% dextran sulfate, 11 Denhardt’s me- in NTB-2 Kodak emulsion, for autoradiography. After ex-
posure at 47, the slides were developed, counterstaineddium, 0.5 mg/ml yeast RNA, 10 mM DTT. The probe was
used at a final concentration of 5 1 104 cpm/ml. After with hematoxylin and eosin and mounted in Permount
medium (Fisher).
RESULTS
Detection of BDV antigen and RNA in human autopsy
brain samples
Degeneration of neurons within the hippocampal for-
mation and intense astrocytosis have been documented
as the main histopathological findings in BDV-infected
animals (Carbone et al., 1991; Rott and Becht, 1995).
Therefore we conducted a survey of a total of 600 autopsy
cases that are part of the ADRC neuropathology data-
base to identify cases with similar histopathological char-
acteristics. Five cases were found as having HS as the
main histopathological finding (Fig. 1). These cases were
selected for our studies which also included 26 randomly
chosen AD cases, 3 LBV cases, and 2 cases free of
clinical and histopathological symptoms. The 5 patients
with HS had a clinical history of memory alterations and
depression that lasted for 2 to 8 years (Table 1). Neuro-FIG. 2. Specificity of the rabbit anti-BDV p40 antibody (Rba-BDVp40
pathological examination of these cases revealed signifi-Ab) used in this study. (A) Immunofluorescence assay. C6, C6BV cells,
and C6 cells transfected with CMV-BDVp40 were analyzed for BDVp40 cant atrophy of the brain affecting mainly the temporal
expression by immunofluorescence as described under Materials and lobe and hippocampus. Microscopic examination of the
Methods. (B) Western blot and immunoprecipitation assays. Whole ex- cresyl violet- and H/E-stained hippocampal sections
tracts from C6 and C6BV cells, and from C6 cells transfected with CMV-
showed pyramidal cell loss that was most prominent inBDVp40 or a plasmid expressing the b-galactosidase gene (CMV-b-
cornus ammonis region 1 (CA1) and the prosubiculumgal) were prepared and analyzed by Western blot (WB) and immunopre-
cipitation (IP) as described under Materials and Methods. in all 5 HS cases. In 2 of the HS cases, sclerosis of the
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FIG. 3. Expression of BDV p40 antigen and GFAP in two representative examples of HS and AD cases. Hippocampal sections of two HS cases
(A, E, B, and F) and two AD cases (C, G, D, and H) were stained with either Rba-BDVp40 Ab (A–D) or an anti-GFAP antibody (E–H) following
procedures described under Materials and Methods.
hippocampal formation was the only neuropathological ing cells in the CNS, or other additional structural dam-
age within the brain parenchyma (Fig. 1). Table 1 summa-finding. Two other HS cases contained some plaques
and occasional tangles in the limbic system and neocor- rizes clinical records corresponding to the cases exam-
ined in this report.tex. The remaining HS case had some plaques and tan-
gles, as well as Lewy bodies warranting a diagnosis of We next examined whether expression of BDV anti-
gens could be detected in autopsy brain material fromLBV. None of these HS cases presented neuropathologi-
cal characteristics compatible with Pick’s disease, these cases. For this purpose, we conducted immunocy-
tochemical studies using a rabbit polyclonal antibodyCreutzfeldt–Jakob disease, or lobar atrophy with Lewy
bodies. Moreover, none of them showed signs of infiltrat- raised against the BDV p40 antigen (Rba-BDVp40 Ab).
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cytes. In contrast, none of the AD or LBV cases or cases
without neuropathology showed immunoreactivity with
the Rba-BDVp40 Ab. However, as previously docu-
mented (Eng and Ghirnikar, 1994; Le Prince et al., 1993),
AD cases displayed a significant astrocytosis as deter-
mined by GFAP staining of astrocytes (Fig. 3).
To rule out the possibility that the Rba-BDVp40 Ab
contained antibodies that did not recognize BDV p40 but
rather a cross-reacting antigen expressed in brain tissue
of the HS cases, we conducted competition experiments.
Adsorption of the Rba-BDVp40 Ab with extracts from Sf9
cells infected with a recombinant baculovirus expressing
the BDV p40 antigen prevented the staining of brain sec-
tions from HS cases (Fig. 4). Additional control experi-
ments showed that the Rba-BDVp40 Ab immunoreactivity
was only associated with BDV-infected cultured cells but
not with uninfected control cells, and that the rabbit pre-
immune serum did not stain brain sections from HS
cases (not shown).
We next examined whether the detection of BDV p40
antigen in HS cases correlated with the presence of
viral RNA. We analyzed 12 of the 36 autopsy cases for
expression of BDV RNA. These cases included the 5
HS cases and 7 AD cases. RNA extracted from snap-
frozen material was reverse transcribed using random
hexamers as primers and the cDNAs were amplified
by PCR using specific primers to amplify a 528-bp seg-
ment of BDV p40 gene. As a control for RNA quality, we
also amplified a 192-bp fragment of GAPDH, a cellular
housekeeping gene. These studies were conducted
under blind conditions. After completion of the experi-
ment the code was broken. The results showed that
PCR products with the expected size of 528 bp wereFIG. 4. Specificity of Rba-BDVp40 Ab staining. Hippocampal sections
obtained only with RNA extracted from brain tissue offrom a HS case were stained with the Rba-BDVp40 Ab that had been
preadsorbed with extracts from Sf9 cells infected (A) with a wild-type the 4 HS cases which were also positive for BDV p40
baculovirus or (B) with a recombinant baculovirus expressing the BDV antigen expression (Fig. 5). In contrast, case HS-1 that
p40 antigen. was negative for expression of BDV p40 antigen was
also BDV negative by RT-PCR as well as all 7 AD cases
(Fig. 5). RNA samples from autopsy material of normalThis antibody was prepared with purified recombinant
bacterially expressed viral antigen and specifically rec- control brains were also BDV negative by RT-PCR (not
shown). The specificity of the PCR products was veri-ognizes the BDV p40 protein, as determined by immuno-
fluorescence, Western blot, and immunoprecipitation fied by Southern blot hybridization using a BDV-spe-
cific probe internal to the 528-bp fragment of BDV p40assays with uninfected and BDV persistently infected
cells (Fig. 2). Four of the five HS cases showed expres- (Fig. 5). Treatment of RNA samples with DNase-free
RNase, but not with RNase-free DNase, prior to thesion of BDV p40 antigen in astrocytes and neurons (Fig.
3). The anti-BDV p40 antibody labeled very strongly the RT-PCR assay prevented amplification of both BDV p40
and GAPDH sequences (not shown). In addition, RT-pyramidal neurons in the cornus ammonis. The immuno-
reactivity was more intense in the CA4 and CA3 than PCR control experiments consisting of the omission of
the reverse transcriptase in the RT step also resultedin the CA2 and CA1 regions. No immunostaining was
observed in the dentate granular cells. Occasional proto- in absence of BDV p40 and GAPDH PCR products (Fig.
6A). Priming of the RT reaction with a BDV p40-specificplasmic astrocytes in the hilar region showed moderate
anti-BDV p40 immunoreactivity. Immunolabeling of brain primer of genomic polarity (antisense with respect to
the BDV p40 ORF), allowed PCR amplification of thesections from HS cases with an antibody to GFAP re-
vealed intense astrocytic reaction in the hilar region, cor- 528-bp BDV p40 fragment in three HS cases (HS-2, 3,
and 4, Fig. 6B), whereas in one case (HS-5, Fig. 6B),nus ammonis, and subiculum. Protoplasmic astrocytes
were more abundant and prominent than fibrilar astro- amplification of the BDV p40 DNA fragment occurred
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FIG. 5. RT-PCR analysis of RNA extracted from HS and AD cases. RNA was extracted from frozen brain samples of HS and AD cases. Total RNA
from C6 and C6BV was included as negative and positive controls, respectively. To prevent possible contaminations due to the high levels of BDV
p40 RNA sequences present in C6BV cells, this RNA sample was processed separately from the others, and the corresponding RT-PCR product
used as positive control in RT-PCR and Southern blot hybridization analysis. Total RNA was reverse transcribed using random hexamers as primers.
Aliquots corresponding to 1/10 of the cDNA products were amplified by nested PCR using specific primers for BDV p40 to generate a 528-bp
fragment DNA. An aliquot of cDNA from each sample was also used to amplify by PCR GAPDH sequences as a control of RNA quality and to rule
out the presence in the RNA samples of possible inhibitors of the RT-PCR assay. For each sample 1/5 and 1/10 of the BDV p40 and GAPDH PCR
products, respectively, were combined and analyzed by agarose gel electrophoresis followed by (i) ethidium bromide staining and (ii) Southern blot
hybridization using a BDV p40 probe internal to the expected PCR product. M, 100-bp ladder (GIBCO BRL).
only when random hexamers were used as primers for tion, sections from snap-frozen brain tissue gave a
much stronger GAPDH signal, but they exhibited poorerthe RT reaction.
We then used a different procedure to confirm the morphology (compare Figs. 7G and 7H).
presence of BDV RNA sequences in brain material from
HS cases. Brain sections from case HS-3 of Fig. 5, and DISCUSSION
an AD case corresponding to the one analyzed by RT-
PCR on lane 4 of Fig. 5, were analyzed by ISH using In this report we document for the first time evidence
of BDV infection in human brain tissue. We detected bothan antisense BDV p40 riboprobe (Fig. 7). We detected
positive hybridization signal in the HS case (Figs. 7B BDV antigen and RNA in sections from autopsy brain
material of four patients who presented with clinical his-and 7D), but not in the AD case (Figs. 7A and 7C). The
positive cells were located in the same region as those tories of mental disorders. In contrast, markers of BDV
infection were not detected in AD and normal controlfound positive for the expression of BDV p40 antigen.
The specificity of the probe was verified by ISH using cases. Our results represent a first and necessary step
aimed at understanding the mechanisms by which BDVuninfected (Fig. 7E) and BDV persistently infected (Fig.
7F) C6 cells. Brain sections from two other AD cases could contribute to disturbances in CNS functions.
Similarly to infections with other NNS RNA virusesanalyzed were also negative by ISH (not shown). We
also analyzed brain sections from case HS-5 of Fig. 5, (Tordo et al., 1992), BDV p40 antigen, the virus nucleopro-
tein, is expressed at high levels in infected cells (Cubittbut no specific hybridization was detected (not shown).
Hybridization with an antisense GAPDH riboprobe gave and de la Torre, 1994; Cubitt et al., 1994a). Therefore, we
reasoned that BDV p40 represented a good marker topositive signals in brain sections from both AD and HS
cases (Fig. 7G). However, the GAPDH signal obtained search for BDV infection in human brain tissue. We fo-
cused our search on cases with clinical and histopatho-in paraffin sections in all cases was significantly
weaker than expected, based on our experience with logical characteristics bearing resemblances to findings
reported for BDV-infected animals. BDV exhibits a strongbrain sections from experimental animals. This sug-
gests that conditions of tissue preservation were not tropism for limbic system structures (Gosztonji and Lud-
wig, 1995), and damage to the hippocampal formationoptimal for ISH studies. Consistent with this observa-
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of BDV infection (Gosztonji and Ludwig, 1995). None of
the HS cases showed signs of inflammation within the
brain parenchyma. The possibility that the immunoreac-
tivity of the rabbit anti-BDV p40 serum observed on brain
tissue of these HS cases represents the expression of
a cross-reacting antigen rather than BDV p40 was ruled
out because of: (i) the specificity of the anti-BDV p40
antibody as determined by immunofluorescence, West-
ern blot, and immunoprecipitation assays (Fig. 2) and (ii)
the ability to block the immunoreactivity by preadsorption
with cell extracts containing high levels of BDV p40 anti-
gen (Fig. 4). Further, none of the 26 autopsy-confirmed
AD and normal brain cases examined was found positive
for BDV p40 antigen expression, arguing for the specific-
ity of the BDV infection and the reagents employed in
this study, and against the notion that long-term hospital-
ization is solely associated with increased exposure to
BDV infection.
Results from RT-PCR studies showed a perfect correla-
tion between the detection of BDV p40 antigen and RNA.
In addition, none of the seven AD cases analyzed by RT-
PCR was found positive for BDV sequences, whereas in
all these AD cases we could amplify RNA sequences of
the cellular housekeeping gene GAPDH. The RT-PCR
conditions selected to detect BDV RNA were based on
the assumption that the autopsy tissue samples may
harbor only very low levels of RNA target sequences.
The use of nested PCR provides an overall increase in
sensitivity and specificity over that achieved by single
FIG. 6. (A) Amplification of BDV p40 sequences using RNA extracted
PCR (Simmonds et al., 1990). The possibility of contami-from HS cases requires the use of reverse transcriptase. (B) Polarity
nation with a laboratory source of BDV sequences duringof the BDV RNA target detected by RT-PCR in HS cases.
these studies can be ruled out based on the following
reasons: (i) tissue collection and storage was done in
ADRC facilities at UCSD where no work has been con-constitutes a main histopathological hallmark of natural
and experimental BDV infection in animals of different ducted with BDV, (ii) RNA extraction from brain tissue
samples was done in facilities where BDV work is notspecies (Carbone et al., 1991; Gosztonji and Ludwig,
1995). The hippocampus is thought to play a role in learn- conducted, (iii) strict separation between pre-PCR and
post-PCR environments was observed, (iv) the seven ADing, memory, and emotional behavior (Alvarez and
Squire, 1994; Baxendale, 1995; Buzsaki et al., 1990), all cases and five HS cases were analyzed by RT-PCR under
blind conditions, and (v) results from minus-RT controlof which are affected by BDV infection (Bautista et al.,
1994; Dittrich et al., 1989; Narayan et al., 1983). In addi- experiments indicated that we did not amplify contami-
nant DNA.tion, changes in brain structure and function affecting the
hippocampal formation have been described in patients In cases HS-2, 3, and 4 (Fig. 7B) we detected BDV
p40 sequences of sense polarity corresponding toaffected with schizophrenia and mood disorders (Yolken
and Torrey, 1995). However, immune cell infiltrates are mRNA, suggesting an active BDV infection. Failure to
detect BDV p40 sequences with mRNA polarity in caseusually not observed in autopsy brain tissue from pa-
tients who presented with these mental disorders. Inter- HS-5 (Fig. 7B) could reflect inappropriate conditions of
tissue preservation leading to a poor quality of mRNA.estingly, BDV-induced brain damage in both naturally and
experimentally infected animals can occur not only via Similarly to other NNS RNA viruses, the encapsidation
of BDV genome RNA into RNPs confers it with a higherimmunological assault (Narayan et al., 1983; Stitz et al.,
1995), but also as a result of direct cell damage due to degree of protection against RNases (Briese et al.,
1992; Tordo et al., 1992). Since we could amplifyvirus replication (Carbone et al., 1991).
We detected expression of BDV p40 antigen in 4 of 5 GAPDH RNA sequences from HS-5 brain tissue sample
to levels similar to those reached in cases HS-2, 3,HS cases examined. Viral antigen was found in both the
cytoplasm and the nucleus of positive cells, an observa- and 4, overall mRNA degradation is unlikely the reason
for the failure to detect BDV p40 mRNA sequences intion consistent with findings reported in animal models
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FIG. 7. Detection of BDV p40 mRNA sequences in case HS-3 by in situ hybridization. Tissue sections were hybridized with a 35S-labeled antisense
riboprobe. Autoradiography exposure time was 30 days and slides were counterstained with hematoxylin and eosin. The hippocampal area of (A,C)
an AD control case and (B,D) case HS-3 is shown at two different magnifications (1100 and 1250, respectively). Arrows in A and B point to the
areas shown at a higher magnification in C and D, respectively. In D, representative examples of cells containing a hybridization signal corresponding
to BDV p40 mRNA are shown (arrows). As control of probe specificity, we used the same probe to perform ISH on (E) uninfected C6 or (F) BDV-
infected C6BV cells. Exposure time was 16 hr. Magnification 1250. To evaluate the quality of RNA, ISH using a GAPDH antisense riboprobe was
performed using either (G) paraffin-embedded or (H) frozen sections. Signals obtained in the two samples are identical in intensity but required 30
days of exposure time for the paraffin-embedded sample versus 26 hr for the snap-frozen section.
this case. Interestingly, ISH using a BDV p40 antisense are productively infected with BDV. Similarly to other neu-
rotropic viruses (Gabuzda and Hirsch, 1987), BDV couldriboprobe showed positive BDV RNA signal in HS-3
but not in HS-5. This result would be consistent with gain access to the CNS by shedding from monocytes/
macrophages during circulation through the brain. Nei-the hypothesis that case HS-5 may represent a BDV
persistent infection characterized by very low levels of ther frozen PBMC nor serum samples were available
from the HS cases analyzed here. Therefore, we couldgenome transcription, but accumulation of stable viral
nucleocapsids containing BDV p40 as the main protein not examine whether detection of BDV antigen and RNA
in the CNS correlated with the presence of BDV RNA incomponent and encapsidated genomic RNA.
How BDV enters the human CNS remains to be deter- PBMC or viral antibodies in serum. The possibility of
recovering infectious virus from frozen specimens foundmined. Recently, BDV has been detected in PBMCs from
humans and both naturally and experimentally BDV-in- positive for BDV antigen and RNA is currently under in-
vestigation.fected animals (Bode et al., 1995; de la Torre et al., 1996;
Kishi et al., 1995; Sierra-Honigmann et al., 1993). These Hippocampal sclerosis is often seen in the setting of
long-standing epilepsy usually in young individuals, butfindings suggest that BDV is also a hematopoietic cell-
related virus. Within PBMCs, monocytes have been pro- whether HS is the cause or the result of epilepsy remains
controversial. None of the cases investigated in thisposed to be the main cell type harboring BDV antigens
and RNA (Bode, 1995), whereas the recent isolation of study had epilepsy. HS has been associated recently
with dementia in older subjects (Dickson et al., 1994). Theinfectious BDV from PBMCs of neuropsychiatric patients
(de la Torre et al., 1996) suggests that these monocytes cause of HS in those cases was unknown, but anoxic/
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tial pathogenic implications. In ‘‘Borna Disease’’ (H. Koprowski andischemic insults might be involved. The neuropathologi-
I. Lipkin, Eds.), pp. 103–130. Springer-Verlag, Berlin.cal findings associated with the HS cases reported here
Bode, L., Zimmermann, W., Ferszt, R., Steinbach, F., and Ludwig, H.
are similar to those described in elderly individuals with (1995). Borna disease virus genome transcribed and expressed in
dementia (Dickson et al., 1994). It is conceivable that HS psychiatric patients. Nat. Med. 1, 232–236.
Brahic, M., and Ozden, S. (1992). Simultaneous detection of cellularrepresents a terminal neuropathological alteration that
RNA and proteins. In ‘‘In Situ Hybridization—A Practical Approach’’could be caused by a variety of insults, including a long-
(R. G. Wilkinson, Ed.), pp. 85–104. IRL Press, Oxford.term persistent infection with BDV in the CNS.
Briese, T., de la Torre, J. C., Lewis, A., Ludwig, H., and Lipkin, W. I.
The area of the hippocampus most affected in cogni- (1992). Borna disease virus, a negative-strand RNA virus, transcribes
tively impaired elderly individuals (with or without a clini- in the nucleus of infected cells. Proc. Natl. Acad. Sci. USA 89, 11486–
11489.cal history of cardiovascular disease), as well as in ex-
Briese, T., Schneemann, A., Lewis, A. J., Park, Y. S., Kim, S., Ludwig,perimental models of anoxia and BDV infection is the
H., and Lipkin, W. I. (1994). Genomic organization of Borna diseaseCA. In experimental animal models of BDV infection the
virus. Proc. Natl. Acad. Sci. USA 91, 4362–4366.
dentate granular cells also express viral antigen and Buzsaki, G., Chen, L. S., and Gage, F. H. (1990). Spatial organization
eventually degenerate. However, overt alterations in the and physiological activity in the hippocampal region: Relevance to
memory formation. Prog. Brain Res. 83, 257–268.dentate gyrus were not observed in the HS cases des-
Carbone, K. M., Park, S. W., Rubin, S. A., Waltrip, R. W., II, and Vogelsang,cribed here, and have not been observed in humans,
G. B. (1991). Borna disease: Association with a maturation defect inexcept in severe cases of HS or in Pick’s disease. The
the cellular immune response. J. Virol. 65, 6154–6164.
reasons for these differences in neuropathological find- Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA
ings between BDV-infected rats and the human HS cases isolation by acid guanidinium thiocyanate–phenol–chloroform ex-
traction. Anal. Biochem. 162, 156–159.found positive for BDV antigen and RNA are presently
Cubitt, B., and de la Torre, J. C. (1994). Borna disease virus (BDV), aunknown. Nonetheless, the finding of viral antigen and
nonsegmented RNA virus, replicates in the nuclei of infected cellsneuronal damage exclusively in the CA region can be
where infectious BDV ribonucleoproteins are present. J. Virol. 68,
explained by the fact that BDV spreads following the 1371–1381.
known connectivity of the hippocampus from the dentate Cubitt, B., Oldstone, C., and de la Torre, J. C. (1994a). Sequence and
genome organization of Borna disease virus. J. Virol. 68, 1382–1396.granular cells to the pyramidal cells.
Cubitt, B., Oldstone, C., Valcarcel, J., and de la Torre, J. C. (1994b). RNAWhether BDV infection contributes to the etiology of
splicing contributes to the generation of mature mRNAs of Bornamental disorders similar to those displayed by the BDV-
disease virus, a non-segmented negative strand RNA virus. Virus
positive HS cases here described warrants further inves- Res. 34, 69–79.
tigations. The availability of highly specific BDV probes de la Torre, J. C. (1994). Molecular biology of Borna disease virus:
Prototype of a new group of animal viruses. J. Virol. 68, 7669–7675.and screening procedures should encourage a compre-
de la Torre, J. C., Bode, L., Du¨rrwald, R., Cubitt, B., and Ludwig, H.hensive search of brain banks for autopsy cases with
(1996). Molecular characterization of Borna disease virus isolatedclinical and histopathological characteristics similar to
from peripheral blood mononuclear cells of psychiatric patients. Virus
those described here as BDV positive, and these materi- Res., in press.
als tested for expression of BDV. Such studies will allow Dickson, D. W., Davies, P., Bevona, C., Van Hoeven, K. H., Factor,
S. M., Grober, E., Aronson, M. K., and Crystal, H. A. (1994). Hippocam-us to determine the contribution of BDV to the pathophys-
pal sclerosis: A common pathological feature of dementia in veryiology of human mental disorders of unknown etiology.
old ( or  80 years of age) humans. Acta Neuropathol. 88, 212–
221.
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